An Iraqi judoka recorded the first positive doping test of the 2024 Paris Olympics, as confirmed by the International Testing Agency (ITA) on Friday. The athlete tested positive for banned anabolic steroids methandienone and boldenone at the Games. The ITA revealed that the sample which was collected from Sajjad Sehen "returned an adverse analytical finding for the non-specified prohibited substances metandienone and boldenone".
Both drugs are banned by the World Anti-Doping Agency.
The sample was collected by the ITA during an out-of-competition anti-doping control on Tuesday in Paris, with the result reported by the WADA-accredited laboratory of Paris on Thursday.
The 28-year-old first-time Olympian had been due to compete next week in the men's 81-kilogram class.
The ITA statement said the athlete had been provisionally suspended until the resolution of the matter.
Paris Olympics 2024 Live updates: Opening ceremony
"This means that the athlete is prevented from competing, training, coaching, or participating in any activity during the Olympic Games Paris 2024," it said.
The manager of Iraq's delegation, Herda Raouf, told AFP that Sehen and his coach would be questioned by doping chiefs on Saturday.
"It is worth noting that the player had previously undergone a surgical operation, which may have caused him to take some type of medication," Raouf said.
{{/usCountry}}"It is worth noting that the player had previously undergone a surgical operation, which may have caused him to take some type of medication," Raouf said.
{{/usCountry}}The ITA said Sehen had the right to challenge his provisional suspension at the Court of Arbitration for Sport and can also request an analysis of the B sample.
The ITA manages an independent anti-doping programme for the Olympics in Paris on behalf of the International Olympic Committee.
(with inputs from agencies)